Pulmonary Embolism at CT Pulmonary Angiography in Patients with COVID-19
- PMID: 33778610
- PMCID: PMC7336753
- DOI: 10.1148/ryct.2020200308
Pulmonary Embolism at CT Pulmonary Angiography in Patients with COVID-19
Abstract
Purpose: To evaluate pulmonary embolism (PE) prevalence at CT pulmonary angiography in patients testing positive for coronavirus disease 2019 (COVID-19) and factors associated with PE severity.
Materials and methods: A retrospective, single-center study evaluated 62 patients who tested positive for COVID-19 who underwent CT pulmonary angiography between March 13 and April 5, 2020. Another 62-patient cohort who underwent CT pulmonary angiography before the first reported local COVID-19 case was retrospectively selected. The relative rate of CT pulmonary angiography positivity was recorded. For the COVID-19 positive cohort, comorbidities, laboratory values, clinical outcome, and venous thrombosis of the patients were recorded. Two thoracic radiologists assessed embolic severity using the Mastora system and evaluated right heart strain. Factors associated with PE and arterial obstruction severity were evaluated by using statistical analysis. A P value < .05 was considered significant.
Results: Of the patients testing positive for COVID-19, 37.1% had PE, higher than 14.5% of pre-COVID-19 patients (P = .007). d-dimer levels closest to CT pulmonary angiography date correlated with the Mastora obstruction score. Receiver operating characteristic analysis identified optimal sensitivity (95%) and specificity (71%) for PE diagnosis at 1394 ng/mL d-dimer units. The mean d-dimer level was 1774 ng/mL and 6432 ng/mL d-dimer units in CT pulmonary angiography-negative and CT pulmonary angiography-positive subgroups, respectively (P < .001). One additional patient with negative results at CT pulmonary angiography had deep venous thrombosis, thus resulting in 38.7% with PE or deep venous thrombosis, despite 40% receiving prophylactic anticoagulation. Other factors did not demonstrate significant PE association.
Conclusion: A total of 37.1% of COVID-19 patients underwent CT pulmonary angiographic examinations diagnosing PE. PE can be a cause of decompensation in patients testing positive for COVID-19, and d-dimer can be used to stratify patients in terms of PE risk and severity.Supplemental material is available for this article.© RSNA, 2020.
2020 by the Radiological Society of North America, Inc.
Conflict of interest statement
Disclosures of Conflicts of Interest: M.K. disclosed no relevant relationships. W.M. disclosed no relevant relationships. K.F. disclosed no relevant relationships. J.S.B. disclosed no relevant relationships. D.K. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: author paid by OncLive Heme Malignancy for lecture on treatment of relapse/refractory multiple myeloma. Other relationships: disclosed no relevant relationships. L.I.H. disclosed no relevant relationships. G.M. disclosed no relevant relationships. A.K. disclosed no relevant relationships. J.P.K. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: institution receives grant from Siemens for research collaboration on lung nodule evaluation on CT. Other relationships: disclosed no relevant relationships.
Figures
Comment in
-
Pulmonary artery thrombosis in COVID-19 patients.Pulmonology. 2021 May-Jun;27(3):261-263. doi: 10.1016/j.pulmoe.2020.07.013. Epub 2020 Aug 24. Pulmonology. 2021. PMID: 32873513 Free PMC article. No abstract available.
References
-
- Simpson S, Kay FU, Abbara S, et al. . Radiological Society of North America Expert Consensus Statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging 2020;35(4):219–227. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
